[Influence of age on indications and modalities of radiation therapy: What to keep in mind for adolescents and young adults?]

Impact de l’âge et radiothérapie : points clés chez les AJA.
Adolescents and young adults Adolescents et jeunes adultes Combined treatment Dose Indication Long-term toxicity Radiation therapy Radiothérapie Target volume Technique Toxicité à long terme Traitements combinés Volume cible

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 22 06 2020
revised: 25 08 2020
accepted: 06 09 2020
pubmed: 15 10 2020
medline: 20 2 2021
entrez: 14 10 2020
Statut: ppublish

Résumé

When using radiation therapy for adolescents and young adults (AYA), paediatricians, adults' oncologists and radiation oncologists need to keep in mind several particularities through the whole therapeutic process. They embrace the indication, target volumes, prescribed dose, treatment techniques and follow-up. Indeed, the young age and the cancer features that characterised this population influence the modalities of irradiation. This article highlights the key points of AYA care with radiation therapy.

Identifiants

pubmed: 33051053
pii: S0007-4551(20)30380-5
doi: 10.1016/j.bulcan.2020.09.004
pii:
doi:

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

203-209

Informations de copyright

Copyright © 2020 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Emmanuel Jouglar (E)

Institut de cancérologie de l'ouest, service de radiothérapie, boulevard Jacques-Monod, 44800 Saint-Herblain, France. Electronic address: Emmanuel.Jouglar@ico.unicancer.fr.

Alexandre Escande (A)

Centre Oscar-Lambret, département universitaire de radiothérapie, 59800 Lille, France; Université de Lille 3, faculté Henri-Warembourg, Laboratoire cristal UMR 9189, 59800 Lille, France.

Valentine Martin (V)

Gustave-Roussy, département universitaire de radiothérapie, 94800 Villejuif, France.

Charlotte Demoor-Goldschmidt (C)

Université Paris-Saclay, Université Paris-Sud, UVSQ, cancer et radiothérapie, Inserm U1018, 94800 Villejuif, France.

Christian Carrie (C)

Centre Léon-Berard, département de radiothérapie, 69008 Lyon, France.

Line Claude (L)

Centre Léon-Berard, département de radiothérapie, 69008 Lyon, France.

Valérie Bernier-Chastagner (V)

Institut de cancérologie de Lorraine, département de radiothérapie, 3, avenue de Bourgogne, 54500 Vandoeuvre-lès-Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH